COVID-19 Update | May 22, 2020

COVID-19 News

COVID-19 Update | May 22, 2020

May 22, 2020

The California Biotechnology Foundation is committed to keeping you up to date on COVID-19 testing, treatment and prevention advancements. The following resources track what progress has been made as of May 22, 2020. Notable advancements include:

  • Gilead Sciences has increased the number of remdesivir doses it is donating to the U.S. federal government from 607,000 to around 940,000.
  • AstraZeneca has concluded the first agreements for at least 400 million doses of the University of Oxford’s COVID-19 vaccine and has secured manufacturing capacity for one billion doses beginning first deliveries in September 2020.
  • Pfizer is expanding their research and manufacturing capacity to fulfill 20 million COVID-19 vaccine doses by the end of the year and advance clinical trials for antiviral treatments.

Recent News:

Rely on California Biotechnology Foundation to monitor breaking news and provide updates on the latest advancements in COVID-19 diagnostics, vaccines and treatments.


Stay informed on the latest news and trends on the economic and health benefits of this industry by visiting the new


If you have any questions about informational briefings contact California Biotechnology Foundation Executive Director Patty Cooper at (916)764-2434 or [email protected].